Many patients are relieved or excited to be finished with initial breast cancer
treatment. But it can also be a time of worry for women who fear their cancer
could come back, or who feel lost without the same frequency of visits with
their cancer care team.
Even after a patient completes breast cancer treatment, doctors will want to
watch the patient closely. It's very important for patients to go to all follow-up
appointments. During these visits, doctors will ask if they are having any problems.
They may do exams and lab tests or imaging tests to look for signs of cancer or
treatment side effects. Plus, some patients may still be taking a HER2 inhibitor or are on endocrine therapy.
Here find what the National Compreh
ensive Cancer Network (NCCN) suggests for long term breast cancer follow-up. Also, go to NCCNs Survivorship Guidelines here.
The National Comprehensive Cancer Network (NCCN) empowers patients to make
informed decisions at each step of their cancer journey.
The NCCN Guidelines for Patients and NCCN Quick Guide™ sheets are based on
the same treatment information you use and help patients talk to you about the best treatment options for their disease. These step-by-step guides to the latest advances in cancer care feature q
uestions to ask, patient-friendly illustrations, glossaries of terms and acronyms.
From Idea to Cure
Cancer Research Then, Now and Tomorrow
This year on October 5th at the 21st annual women's health and cancer conference attendees will hear the latest advances in cancer prevention, detection, treatment and survivorship.
To view the 2018 Women's Health and Cancer Conference brochure
About 10 to 20 percent of breast cancers are triple negative, one of the most aggressive
forms of breast cancer. Triple negative breast cancer (TNBC) patients have a 77 percent
five-year survival rate compared to 93 percent of women with other types of breast cancer,
in part because they are less likely to pursue chemotherapy treatments that offer the
highest chance of survival.
In an effort to improve survival rates and health outcomes, the CDC Division of Cancer Prevention and Control engaged with the National Association of Chronic Disease
Directors and health simulation company Kognito, the leading developer of health
education simulations, to create "Talk to Someone: Triple Negative Breast Cancer."
